Skip to content
Independent analysis of NHS open data
PharmaInsight

Tadalafil (Vasodilator Antihypertensive) vs Doxazosin mesilate

National NHS prescribing compared (Prescription Cost Analysis)
Data updated May 2025

Doxazosin mesilate was dispensed 647,932.0× as often as Tadalafil (Vasodilator Antihypertensive) in May 2025 — 647,932 items versus 1 in England.

1items

Tadalafil (Vasodilator Antihypertensive) · May 2025

NHSBSA Prescription Cost Analysis

647,932items

Doxazosin mesilate · May 2025

NHSBSA Prescription Cost Analysis

Figure 1. Tadalafil (Vasodilator Antihypertensive) versus Doxazosin mesilate: national items dispensed by month

▬ Tadalafil (Vasodilator Antihypertensive)   ·   ╌ Doxazosin mesilate

0 346k 691k Jan 2021 Aug 2021 Mar 2022 Oct 2022 May 2023 May 2025 Doxazosin mesila… 1 Jan 2021: 1 Feb 2021: 2 Apr 2021: 2 Jun 2021: 1 Jul 2021: 1 Aug 2021: 1 Oct 2021: 2 Dec 2021: 1 Jan 2022: 1 Feb 2022: 1 Mar 2022: 1 Apr 2022: 1 Jun 2022: 2 Aug 2022: 2 Sep 2022: 1 Oct 2022: 1 Nov 2022: 1 Dec 2022: 1 Jan 2023: 3 Mar 2023: 2 May 2023: 2 Jun 2023: 1 Jul 2023: 1 Aug 2023: 1 Nov 2023: 1 Dec 2023: 1 Mar 2024: 1 May 2024: 1 May 2025: 1

Source: NHSBSA Prescription Cost Analysis, to May 2025

Tadalafil (Vasodilator Antihypertensive) versus Doxazosin mesilate, May 2025
Measure Tadalafil (Vasodilator Antihypertensive) Doxazosin mesilate
Items, May 2025 1 647,932
Items, last 12 months 16 7,846,227
Net ingredient cost, May 2025 £105 £2,729,372

See the full profile for Tadalafil (Vasodilator Antihypertensive) or Doxazosin mesilate.